Medicine Description irinotel 40mg
irinotel 40mg Ampoules is a medication that contains irinotecan, which is a topoisomerase I inhibitor. This drug interferes with the DNA replication process in cancer cells by preventing the re-ligation of DNA strands after they have been cleaved. The inhibition of topoisomerase I leads to DNA damage, causing cell death, particularly in rapidly dividing cells typical of cancerous tumors. As a result, irinotecan is effective in disrupting the proliferation of these malignant cells, thereby assisting in the management of colorectal cancer and potentially extending patient survival when used in combination with other chemotherapeutic agents.
Indications and Uses of irinotel 40mg Ampoules
- Treatment of locally advanced or metastatic colorectal cancer.
- Adjuvant therapy following surgical resection of colorectal cancer.
- Part of combination chemotherapy regimens for enhanced efficacy against advanced stages of colorectal cancer.
- Management of cancer that has shown progression or resistance to prior therapies.
Side Effects of irinotel 40mg Ampoules
- Nausea and vomiting.
- Diarrhea.
- Abdominal pain.
- Fatigue and weakness.
- Low blood cell counts (neutropenia, anemia).
- Hair loss.
- Increased liver enzymes.
- Allergic reactions.
Storage and Handling
irinotel 40mg Ampoules should be stored in a cool, dry place, protected from light, and at controlled room temperature. It must be kept out of reach of children and disposed of according to local regulations after use.
Patient Advice and Precautions
Patients should be closely monitored for side effects and blood counts during treatment with irinotecan. It is advised to maintain adequate hydration and report any severe gastrointestinal symptoms to healthcare providers promptly. Patients should discuss potential interactions with other medications with their healthcare team and ensure they are under the care of a specialist experienced in oncological therapies.